Regulus Therapeutics to Present at the Oppenheimer Rare & Orphan Disease Summit ...Middle East

PR Newswire - News
Regulus Therapeutics to Present at the Oppenheimer Rare & Orphan Disease Summit
SAN DIEGO, May 14, 2021 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs ("Regulus"), today announced that Jay Hagan, President and Chief Executive Officer of Regulus,...

Hence then, the article about regulus therapeutics to present at the oppenheimer rare orphan disease summit was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Regulus Therapeutics to Present at the Oppenheimer Rare & Orphan Disease Summit )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News